COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

• 收藏
• 分享

专利权人:

Genentech; Inc.

发明人:

Gail Lewis Phillips,Deepak Sampath,Ingrid Wertz

申请号：

US15849018

公开号：

US20180140700A1

申请日:

2017.12.20

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/